Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.691
-0.009 (-1.29%)
At close: Apr 28, 2026, 4:00 PM EDT
0.730
+0.039 (5.64%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $149.95 million as of April 28, 2026. Its market cap has increased by 88.32% in one year.
Market Cap
149.95M
Enterprise Value
60.23M
1-Year Change
88.32%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $149.95M, a decrease of -75.16%. That is a compound annual growth rate of -25.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 149.95M | -2.66% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 159.72M |
| Tiziana Life Sciences | 159.53M |
| Alps Group | 156.07M |
| ProQR Therapeutics | 155.93M |
| Black Diamond Therapeutics | 154.68M |
| Spero Therapeutics | 154.57M |
| Galectin Therapeutics | 152.72M |
| Fate Therapeutics | 151.14M |